Dianthus Therapeutics (DNTH) Accumulated Depreciation & Amortization (2017 - 2025)

Dianthus Therapeutics has reported Accumulated Depreciation & Amortization for 9 years, with the latest figure at $304000.0 in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 57.51% year-over-year to $304000.0; the trailing twelve-month figure through Dec 2025 stood at $304000.0 (up 57.51% YoY), and the FY2025 full-year result was $304000.0, up 57.51% from the prior year.
• Accumulated Depreciation & Amortization for Q4 2025 stood at $304000.0, up from $277000.0 in the prior quarter.
• The five-year high for Accumulated Depreciation & Amortization was $2.0 million in Q4 2021, with the low at $30000.0 in Q4 2022.
• Average Accumulated Depreciation & Amortization over 5 years is $323000.0, with a median of $180000.0 recorded in 2024.
• Year-over-year, Accumulated Depreciation & Amortization sank 98.5% in 2022 and jumped 223.33% in 2023.
• Tracing DNTH's Accumulated Depreciation & Amortization over 5 years: stood at $2.0 million in 2021, then slumped by 98.5% to $30000.0 in 2022, then jumped by 223.33% to $97000.0 in 2023, then surged by 98.97% to $193000.0 in 2024, then jumped by 57.51% to $304000.0 in 2025.
• The last three Accumulated Depreciation & Amortization figures came in at $304000.0 (Q4 2025), $277000.0 (Q3 2025), and $250000.0 (Q2 2025), per Business Quant data.

Peer Comparison